Prevalence of nephrolithiasis in polycystic kidney disease

  • Alma Idrizi
  • Myftar Barbullushi
  • Margarita Gjata
  • Alketa Koroshi
  • Enver Roshi
  • Teuta Backa
  • Sulejman Kodra
  • Nestor Thereska
Research Article


We aim to define the prevalence of nephrolithiasis, the impact of anatomic and metabolic factors to stone formation and prognosis of patients with autosomal dominant polycystic kidney disease in Albania. We included 200 patients with autosomal dominant polycystic kidney from 2002 to 2009. The patients underwent X-ray, renal ultrasonography. We performed the metabolic evaluation of blood and urine. Survival times were calculated as the time to dialysis, transplantation, or death. Kaplan-Meier product-limit survival curves were constructed. Log rank test was used to compare the survival curves. Nephrolithiasis was present in 116 of our patients with autosomal dominant polycystic kidney disease (58%), with a mean age 46.4±5.7 years. Sixty five patients with kidney stones (56%) were women. The stones were composed primarily of urate (47%) and calcium oxalate (39%), and other compounds 14%. In 40% of patients the presence of stones was associated with a history of urinary tract infections and flank pain. In our study the prevalence of nephrolithiasis is 58%, higher than it reported in literature. Except anatomic and metabolic factors, there are other contributor factors to stone formation in our patients such socioeconomic status of patients, geographic zones and dietary habits.


Autosomal dominant polycystic kidney disease Gross hematuria Metabolic factors Nephrolithiasis Urinary tract infections 


  1. [1]
    Wilson PD, Goilav B. Cystic disease of the kidney. Annu Rev Pathol Mech Dis 2: 341–368, 2007CrossRefGoogle Scholar
  2. [2]
    Simon HB, Thompson GJ. Congenital renal polycystic disease. JAMA 159: 657–662, 1955Google Scholar
  3. [3]
    Milutinovic J, Fialkow PJ, Agodoa LY et al. Autosomal dominant polycystic kidney disease: Symptoms and clinical findings. Q J Med 212: 511–522, 1984Google Scholar
  4. [4]
    Delaney VB, Adler S, Bruns FJ et al. Autosomal dominant polycystic kidney disease: Presentation, complications and prognosis. Am J Kidney Dis 5: 104–111, 1985PubMedGoogle Scholar
  5. [5]
    Torres WE, Wilson DM, Hattery RR, Segura JW. Renal stones disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis 22: 513–519, 1993PubMedGoogle Scholar
  6. [6]
    Levine E, Grantham JJ. Calcified renal stones and cyst calcification in autosomal dominant polycystic kidney disease: Clinical and CT study in 84 patients. Am J Roentgenol 159: 77–81, 1992Google Scholar
  7. [7]
    Dalgaard OZ. Bilateral polycystic disease of the kidneys: a follow-up of two hundred and eighty four patients and their families. Acta Med Scand 328(S): 255–256, 1957Google Scholar
  8. [8]
    Segal AJ, Spataro RF, Barbaric ZL. Adult polycystic kidney disease: a review of 100 cases. J Urol 118: 711–713, 1967Google Scholar
  9. [9]
    Gambaro G, Fabris A, Puliatta D, Lupo A. Lithiasis in cystic kidney disease and malformations of the urinary tract. Urol Res 34: 102–107, 2006PubMedCrossRefGoogle Scholar
  10. [10]
    Torres WE, Erickson SB, Smith LH, Wilson DM et al. The association of nephrolithiasis and autosomal dominant polycystic kidney disease. Am J Kidney Dis 11: 318–325, 1988PubMedGoogle Scholar
  11. [11]
    Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P, Danks DM. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease. Lancet 2: 824–827, 1994CrossRefGoogle Scholar
  12. [12]
    Sallée M, Rafat C, Zahar JR, Paulmier B, Grünfeld JP, Knebelmann B, Fakhouri F. Cyst Infections in Patients with Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol 4: 1183–1189, 2009PubMedCrossRefGoogle Scholar
  13. [13]
    Levy FL, Adams-Huet B, Pak CYC: Ambulatory evaluation of nephrolithiasis: An update from 1980. Am J Med 98: 50–59, 1995PubMedCrossRefGoogle Scholar
  14. [14]
    Heilberg IP, Boim MA, Schor N. Biochemical differences between stone formers and normal subjects. In: Stone Disease: 1st International Consultation on Stone Disease, 21st Ed., edited by Segura J, Conort P, Khoury S, Pak C, Preminger GM, Tolley D, France, Health Publications 61–64, 2003Google Scholar
  15. [15]
    Statisical Analysis System, Cary, NC, SAS Institute Inc 1996Google Scholar
  16. [16]
    Cox DR: Regression models and life tables. J R Stat Soc B34: 187–220, 1972Google Scholar
  17. [17]
    Grampsas SA, Chandhoke PS, Fan J et al. Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 36(1): 53–57, 2000PubMedCrossRefGoogle Scholar
  18. [18]
    Torres VE, Harris C, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet 369: 1287–1301, 2007PubMedCrossRefGoogle Scholar
  19. [19]
    Nishiura JL, Neves RFCA, Eloi SRM, Cintra SMLF, Ajzen SA, Heilberg IP. Evaluation of Nephrolithiasis in Autosomal Dominant Polycystic Kidney Disease Patients. Clin J Am Soc Nephrol 4: 838–844, 2009PubMedCrossRefGoogle Scholar
  20. [20]
    Jackman SV, Potter SR, Regan F, Jarrett TW. Plain abdominal x-ray versus computerized tomography screening: sensitivity for stone localization after nonenhanced spiral computerized tomography. J Urol 164(2): 308–310, 2000PubMedCrossRefGoogle Scholar
  21. [21]
    Gabow PA, Duley I, Johnson AM. Clinical profiles of gross hematuria in autosomal dominant polycystic kidney disease. Am J Kidney Dis 20: 140–143, 1992PubMedGoogle Scholar
  22. [22]
    Gabow PA, Johnson AM, Kaehny WD, Kimberling WJ, Lezotte DC, Duley IT, Jones RH: Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 41: 1311–1319, 1992PubMedCrossRefGoogle Scholar
  23. [23]
    Johnson AM, Gabow PA: Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease. J Am Soc Nephrol 8: 1560–1567, 1997PubMedGoogle Scholar

Copyright information

© © Versita Warsaw and Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  • Alma Idrizi
    • 1
  • Myftar Barbullushi
    • 1
  • Margarita Gjata
    • 2
  • Alketa Koroshi
    • 1
  • Enver Roshi
    • 3
  • Teuta Backa
    • 4
  • Sulejman Kodra
    • 1
  • Nestor Thereska
    • 1
  1. 1.Service of NephrologyUHC “Mother Teresa”TiranaAlbania
  2. 2.Service of Internal MedicineUHC “Mother Teresa”TiranaAlbania
  3. 3.Department of Public HealthUHC “Mother Teresa”TiranaAlbania
  4. 4.Department of Internal MedicineUHC “Mother Teresa”TiranaAlbania

Personalised recommendations